Page last updated: 2024-11-05

benzhydrylamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID7036
CHEMBL ID467503
SCHEMBL ID7841
SCHEMBL ID1573580
MeSH IDM0045625

Synonyms (64)

Synonym
HMS1785L01
aminodiphenylmethane
1,1-diphenylmethylamine
.alpha.-aminodiphenylmethane
nsc49127
benzhydrylamine ,
benzenemethanamine, .alpha.-phenyl-
91-00-9
methylamine,1-diphenyl-
(diphenylmethyl)amine
.alpha.-phenylbenzylamine
nsc-49127
methanamine,1-diphenyl-
alpha-phenylbenzylamine
methanamine, 1,1-diphenyl-
einecs 202-032-2
benzenemethanamine, alpha-phenyl-
alpha-phenylbenzenemethanamine
nsc 49127
diphenylmethanamine
OPREA1_187555
benzhydrylamine, 97%
inchi=1/c13h13n/c14-13(11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10,13h,14h
alpha-aminodiphenylmethane
B0124
CHEMBL467503
STK801347
1,1-diphenylmethanamine
AKOS000120236
alpha-phenyl-benzenemethanamin;alpha-phenylbenzenemethanamine
A25935
benzhydryl-amine
BBL009929
methylamine, 1,1-diphenyl-
unii-4bo6iss9dx
4bo6iss9dx ,
BP-11378
FT-0622663
benzhydrylamine [mi]
benzhydryl amine
diphenylmethyamine
c,c-diphenylmethylamine
c,c-diphenyl-methylamine
ph2chnh2
aminodiphenyl methane
1,1-diphenyl methylamine
aminodiphenyl-methane
diphenyl-methanamine
SCHEMBL7841
PB10011
SCHEMBL1573580
amikacin sulfate, antibiotic for culture media use only
Q-200624
Q-103472
mfcd00008059
F0850-6748
DTXSID00238346
benzhydrylamine, purum, >=97.0% (gc)
CS-D1366
BCP18638
AS-12859
AMY10403
EN300-15665
Q27259384
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID353103Displacement of [3H]MK801 from NMDA receptor in rat brain neuronal membrane2009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
NMDA receptor affinities of 1,2-diphenylethylamine and 1-(1,2-diphenylethyl)piperidine enantiomers and of related compounds.
AID1273073Antitubercular activity against Mycobacterium tuberculosis BCG after 7 days by alamar blue assay2016Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4
Synthesis and anti-tuberculosis activity of glycitylamines.
AID353104Ratio of Ki for rat brain NMDA receptor in presence of 100 uM spermine to Ki for rat brain NMDA receptor in absence of spermine2009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
NMDA receptor affinities of 1,2-diphenylethylamine and 1-(1,2-diphenylethyl)piperidine enantiomers and of related compounds.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (20.00)18.7374
1990's1 (6.67)18.2507
2000's2 (13.33)29.6817
2010's9 (60.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.88

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.88 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.99 (4.65)
Search Engine Demand Index39.34 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.88)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]